Compound Detail
CHEMBL514800
APREMILAST 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC
Basic Information
| ChEMBL ID | CHEMBL514800 |
| Name | APREMILAST |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IMOZEMNVLZVGJZ-QGZVFWFLSA-N |
| Therapeutic | ✓ Yes |
6
Targets
24
Activities
1
Assay Types
9
PK Parameters
20
Publications
5
Known Names
20
Indications
1
Mechanisms
Molecular Properties
460.5
MW (Da)
2.43
ALogP
7
HBA
1
HBD
119.1
PSA (Ų)
0.60
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2014 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Phosphodiesterase 4 inhibitor | INHIBITOR | Phosphodiesterase 4 | ✓ | ✓ |
Indications
Arthritis, Psoriatic Behcet Syndrome Immune System Diseases Oral Ulcer Psoriasis Psoriasis Psoriasis Influenza, Human Pneumonia Severe Acute Respiratory Syndrome Spondylitis, Ankylosing Acne Vulgaris Alcoholism Arthritis, Rheumatoid Colitis, Ulcerative Dermatitis Dermatitis, Allergic Contact Dermatitis, Atopic Dermatomyositis Eczema
ATC Classification
L04AA32
apremilast
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSUPPRESSANTS
Activity Summary
IC50 24 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | IC50 | 8.0 | 7.1813 | 10.0 | 8 |
| 3',5'-cyclic-AMP phosphodiesterase 4B CHEMBL275 | IC50 | 7.78 | 7.524 | 16.5 | 5 |
| Unchecked CHEMBL612545 | IC50 | 7.68 | 7.502 | 21.0 | 5 |
| Phosphodiesterase 4 CHEMBL2093863 | IC50 | 7.13 | 7.0875 | 74.0 | 4 |
| PBMC CHEMBL613107 | IC50 | 7.11 | 7.11 | 77.0 | 1 |
| Blood CHEMBL613416 | IC50 | 6.96 | 6.96 | 110.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 11000.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 14000.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 8.333 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 14331.94 | nM | Rattus norvegicus |
| Cmax | 2388.66 | nM | Rattus norvegicus |
| F | 64.0 | % | Rattus norvegicus |
| T1/2 | 3.0 | hr | Rattus norvegicus |
| T1/2 | 5.0 | hr | Rattus norvegicus |
| T1/2 | 1.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine